[Depressive syndrome in gastroenterology: diagnosis and treatment].
The article presents modern data on depressive syndrome, its prevalence and possible reasons for its growth, the role of psychoemotional stress in the development of anxiety depression (AD), as well as psychosomatic diseases and syndromes and modern views on the mechanisms of their formation. The authors discuss methods of revealing and diagnostic criteria of AD and psychosomatic diseases, including those that develop against the background of masked depression. Associations between depressive syndrome and the development of gastroenterological diseases and psychosomatic syndromes such as peptic ulcer, functional dyspepsia, irritated bowel syndromes, chronic cholecystitis, and chronic duodenal obstruction syndrome are discussed in detail. Special attention is paid to treatment of AD in gastroenterological patients using psycho- and hypnotherapy as well as psychotropic drugs such as antidepressives, anxiolytics, neuroleptics, and nootropic agents.
Ia S
IaS
Tsimmerman
I Ia
IIa
Tsimmerman
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002764:Cholecystitis / Q000523:psychology; D002908:Chronic Disease; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy*; D004066:Digestive System Diseases / Q000523:psychology* / Q000628:therapy; D004415:Dyspepsia / Q000523:psychology; D006801:Humans; D006990:Hypnosis; D007415:Intestinal Obstruction / Q000523:psychology; D043183:Irritable Bowel Syndrome / Q000523:psychology; D018697:Nootropic Agents / Q000627:therapeutic use; D015995:Prevalence; D011602:Psychophysiologic Disorders / Q000523:psychology* / Q000628:therapy; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D013315:Stress, Psychological / Q000150:complications / Q000209:etiology; D013577:Syndrome
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D018697:Nootropic Agents; D011619:Psychotropic Drugs